These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37429429)

  • 21. Inhibition of biofilm development of uropathogens by curcumin - an anti-quorum sensing agent from Curcuma longa.
    Packiavathy IA; Priya S; Pandian SK; Ravi AV
    Food Chem; 2014 Apr; 148():453-60. PubMed ID: 24262582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
    Algburi A; Alazzawi SA; Al-Ezzy AIA; Weeks R; Chistyakov V; Chikindas ML
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Explication of the Potential of 2-Hydroxy-4-Methoxybenzaldehyde in Hampering Uropathogenic
    Durgadevi R; Abirami G; Alexpandi R; Nandhini K; Kumar P; Prakash S; Veera Ravi A
    Front Microbiol; 2019; 10():2804. PubMed ID: 31921010
    [No Abstract]   [Full Text] [Related]  

  • 24. In silico maturation of binding-specificity of DNA aptamers against Proteus mirabilis.
    Savory N; Lednor D; Tsukakoshi K; Abe K; Yoshida W; Ferri S; Jones BV; Ikebukuro K
    Biotechnol Bioeng; 2013 Oct; 110(10):2573-80. PubMed ID: 23568752
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Manoharan A; Farrell J; Aldilla VR; Whiteley G; Kriel E; Glasbey T; Kumar N; Moore KH; Manos J; Das T
    Front Cell Infect Microbiol; 2023; 13():1216798. PubMed ID: 37965267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol.
    Wang WB; Lai HC; Hsueh PR; Chiou RY; Lin SB; Liaw SJ
    J Med Microbiol; 2006 Oct; 55(Pt 10):1313-1321. PubMed ID: 17005777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteus mirabilis biofilms and catheter-associated urinary tract infections.
    Jacobsen SM; Shirtliff ME
    Virulence; 2011; 2(5):460-5. PubMed ID: 21921687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Ibicella lutea on uropathogenic Proteus mirabilis growth, virulence, and biofilm formation.
    Sosa V; Zunino P
    J Infect Dev Ctries; 2009 Dec; 3(10):762-70. PubMed ID: 20009277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis.
    Liaw SJ; Lai HC; Wang WB
    Infect Immun; 2004 Dec; 72(12):6836-45. PubMed ID: 15557604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
    Jansen AM; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
    Wasfi R; Abd El-Rahman OA; Mansour LE; Hanora AS; Hashem AM; Ashour MS
    Indian J Med Microbiol; 2012; 30(1):76-80. PubMed ID: 22361765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Virulence factors in Proteus spp. bacteria isolated from urinary tract infections: their detection and importance].
    Klin Mikrobiol Infekc Lek; 2011 Aug; 17(4):129-34. PubMed ID: 22052099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of quorum sensing mediated biofilm development and virulence in uropathogens by Hyptis suaveolens.
    Salini R; Sindhulakshmi M; Poongothai T; Pandian SK
    Antonie Van Leeuwenhoek; 2015 Apr; 107(4):1095-106. PubMed ID: 25656290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.
    Kwiecińska-Piróg J; Skowron K; Zniszczol K; Gospodarek E
    Biomed Res Int; 2013; 2013():930876. PubMed ID: 24151628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.
    Gomaa S; Serry F; Abdellatif H; Abbas H
    Arch Virol; 2019 Sep; 164(9):2265-2275. PubMed ID: 31197549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.
    Esmael A; Abo-Elmaaty SA; Khafaga EM; Abdelrahman S; Hassan MG
    Arch Virol; 2021 Dec; 166(12):3311-3322. PubMed ID: 34559314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.